Entrada Therapeutics Inc (TRDA)
15.05
+0.10
(+0.67%)
USD |
NASDAQ |
May 20, 14:33
Entrada Therapeutics 1 Year Total Returns (Daily): 11.20% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 17, 2024 | 11.20% |
May 16, 2024 | 14.30% |
May 15, 2024 | 13.20% |
May 14, 2024 | 13.52% |
May 13, 2024 | 12.40% |
May 10, 2024 | 20.20% |
May 09, 2024 | 17.80% |
May 08, 2024 | 21.23% |
May 07, 2024 | 14.52% |
May 06, 2024 | 11.39% |
May 03, 2024 | 7.52% |
May 02, 2024 | 13.28% |
May 01, 2024 | 3.84% |
April 30, 2024 | 1.20% |
April 29, 2024 | 5.38% |
April 26, 2024 | -11.83% |
April 25, 2024 | -5.14% |
April 24, 2024 | -11.59% |
April 23, 2024 | -9.92% |
April 22, 2024 | -8.46% |
April 19, 2024 | -20.25% |
April 18, 2024 | -22.26% |
April 17, 2024 | -32.15% |
April 16, 2024 | -26.26% |
April 15, 2024 | -25.28% |
Date | Value |
---|---|
April 12, 2024 | -17.83% |
April 11, 2024 | -12.24% |
April 10, 2024 | -15.12% |
April 09, 2024 | -3.70% |
April 08, 2024 | -2.47% |
April 05, 2024 | -1.15% |
April 04, 2024 | -4.16% |
April 03, 2024 | -9.14% |
April 02, 2024 | -4.28% |
April 01, 2024 | -5.10% |
March 28, 2024 | -4.90% |
March 27, 2024 | -4.01% |
March 26, 2024 | -8.75% |
March 25, 2024 | -11.27% |
March 22, 2024 | -13.98% |
March 21, 2024 | -13.98% |
March 20, 2024 | -14.48% |
March 19, 2024 | -18.22% |
March 18, 2024 | -20.09% |
March 15, 2024 | -6.10% |
March 14, 2024 | -10.23% |
March 13, 2024 | -2.61% |
March 12, 2024 | -4.85% |
March 11, 2024 | -3.37% |
March 08, 2024 | 11.03% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-56.02%
Minimum
Nov 21 2022
127.8%
Maximum
Apr 13 2023
19.37%
Average
11.49%
Median
Dec 26 2023
1 Year Total Returns (Daily) Benchmarks
Catalyst Pharmaceuticals Inc | 31.60% |
Vertex Pharmaceuticals Inc | 30.48% |
Sarepta Therapeutics Inc | -11.69% |
PTC Therapeutics Inc | -43.22% |
GlycoMimetics Inc | -85.32% |